These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12482057)

  • 1. In vitro bactericidal effect of low-dose ultraviolet B in patients with acne.
    Kalayciyan A; Oguz O; Bahar H; Torun MM; Aydemir EH
    J Eur Acad Dermatol Venereol; 2002 Nov; 16(6):642-3. PubMed ID: 12482057
    [No Abstract]   [Full Text] [Related]  

  • 2. Acne phototherapy with a high-intensity, enhanced, narrow-band, blue light source: an open study and in vitro investigation.
    Kawada A; Aragane Y; Kameyama H; Sangen Y; Tezuka T
    J Dermatol Sci; 2002 Nov; 30(2):129-35. PubMed ID: 12413768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No photoinactivation of Propionibacterium acnes with soft laser treatment.
    Johnsson A; Kjeldstad B; Myklebust T
    Dermatologica; 1987; 175(1):50. PubMed ID: 2956136
    [No Abstract]   [Full Text] [Related]  

  • 4. Therapeutic blue light: a different ray of light on an age-old problem.
    Enwemeka CS
    Photomed Laser Surg; 2006 Dec; 24(6):679. PubMed ID: 17199464
    [No Abstract]   [Full Text] [Related]  

  • 5. Propionibacterium acnes susceptibility to low-level 449 nm blue light photobiomodulation.
    Boyd JM; Lewis KA; Mohammed N; Desai P; Purdy M; Li WH; Fourre T; Miksa D; Crane S; Southall M; Fassih A
    Lasers Surg Med; 2019 Oct; 51(8):727-734. PubMed ID: 30919507
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro investigation of anti-acne properties of Mangifera indica L. kernel extract and its mechanism of action against Propionibacterium acnes.
    Poomanee W; Chaiyana W; Mueller M; Viernstein H; Khunkitti W; Leelapornpisid P
    Anaerobe; 2018 Aug; 52():64-74. PubMed ID: 29906773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced expression of dermcidin, a peptide active against propionibacterium acnes, in sweat of patients with acne vulgaris.
    Nakano T; Yoshino T; Fujimura T; Arai S; Mukuno A; Sato N; Katsuoka K
    Acta Derm Venereol; 2015 Sep; 95(7):783-6. PubMed ID: 25673161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro bactericidal effects of 405-nm and 470-nm blue light.
    Guffey JS; Wilborn J
    Photomed Laser Surg; 2006 Dec; 24(6):684-8. PubMed ID: 17199466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of the mechanism of action of nonablative pulsed-dye laser therapy in photorejuvenation and inflammatory acne vulgaris.
    Seaton ED; Mouser PE; Charakida A; Alam S; Seldon PM; Chu AC
    Br J Dermatol; 2006 Oct; 155(4):748-55. PubMed ID: 16965424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study of the bactericidal effects of 5-aminolevulinic acid with blue and red light on Propionibacterium acnes.
    Choi MS; Yun SJ; Beom HJ; Park HR; Lee JB
    J Dermatol; 2011 Jul; 38(7):661-6. PubMed ID: 21352326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative study of the bactericidal effects of indocyanine green- and methyl aminolevulinate-based photodynamic therapy on Propionibacterium acnes as a new treatment for acne.
    Choi SH; Seo JW; Kim KH
    J Dermatol; 2018 Jul; 45(7):824-829. PubMed ID: 29722425
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antibiotic susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne.
    Nishijima S; Akamatsu H; Akamatsu M; Kurokawa I; Asada Y
    J Dermatol; 1994 Mar; 21(3):166-71. PubMed ID: 8014270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility of Propionibacterium acnes, Staphylococcus aureus and Staphylococcus epidermidis to 10 Kampo formulations.
    Higaki S; Morimatsu S; Morohashi M; Yamagishi T; Hasegawa Y
    J Int Med Res; 1997; 25(6):318-24. PubMed ID: 9427165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial evaluation of nadifloxacin (OPC-7251), a new topical quinolone, in acne vulgaris.
    Vogt K; Hahn H; Hermann J; Haustein UF; Blume U; Gollnick H; Orfanos CE
    Drugs; 1995; 49 Suppl 2():266-8. PubMed ID: 8549327
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative activity of the topical quinolone OPC-7251 against bacteria associated with acne vulgaris.
    Vogt K; Hermann J; Blume U; Gollnick H; Hahn H; Haustein UF; Orfanos CE
    Eur J Clin Microbiol Infect Dis; 1992 Oct; 11(10):943-5. PubMed ID: 1486893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Staphylococcus aureus carriage rates and antibiotic resistance patterns in patients with acne vulgaris.
    Delost GR; Delost ME; Armile J; Lloyd J
    J Am Acad Dermatol; 2016 Apr; 74(4):673-8. PubMed ID: 26777099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgG subclasses specific to Staphylococcus epidermidis and Propionibacterium acnes in patients with acne vulgaris.
    Ashbee HR; Muir SR; Cunliffe WJ; Ingham E
    Br J Dermatol; 1997 May; 136(5):730-3. PubMed ID: 9205507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acne and Propionibacterium acnes.
    Bojar RA; Holland KT
    Clin Dermatol; 2004; 22(5):375-9. PubMed ID: 15556721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bacteriology of acne vulgaris and antimicrobial susceptibility of Propionibacterium acnes and Staphylococcus epidermidis isolated from acne lesions.
    Nishijima S; Kurokawa I; Katoh N; Watanabe K
    J Dermatol; 2000 May; 27(5):318-23. PubMed ID: 10875198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Is acne caused by colonization with the "wrong" strain of Propionibacterium acnes? A review of the role of Propionibacterium acnes in acne].
    Lomholt HB; Kilian M
    Ugeskr Laeger; 2008 Apr; 170(15):1234-7. PubMed ID: 18433578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.